Hepatitis B and C in New South Wales prisons: Prevalence and risk factors

Medical Journal of Australia

Volumn 166, Issue 3, 1997, Pages 127-130

  Butler, Tony G ^a   Dolan, Kate A ^b   Ferson, Mark J ^c   McGuinness, Linda M ^d   Brown, Phillip R ^d   Robertson, Peter W ^e  

^a New South Wales Government   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c S W Sydney Area Health Service   (Australia)

^d Justice and Forensic Mental Health Network   (Australia)

^e PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ABORIGINE; ANTIBODY TITER; ARTICLE; AUSTRALIA; HEALTH EDUCATION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; PRISON; RACE DIFFERENCE; RISK FACTOR; VACCINATION; VIRUS CARRIER; VIRUS TRANSMISSION;

EID: 0031044922     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1997.tb140041.x     Document Type: Article

References (17)

1. Acedo A, Campos A, Bauza J, et al. HIV Infection, hepatitis, and syphilis in Spanish prison [letter]. Lancet 1989; 2: 226.
2. Hull HF, Lyons LH, Mann JM, et al. Incidence of hepatitis B in the penitentiary of New Mexico. Am J Public Health 1985; 75: 1213-1214.
3. Koplan JP, Walker JA, Bryan JA. Prevalence of hepatitis B surface antigen and antibody at a state prison in Kansas. J Infect Dis 1978; 137: 505-506.
4. Melico-Silvestre A, Pombo V, Pereira A, et al. Sero-epidemiological survey of transmissible infections in Portuguese prisoners [letter]. AIDS 1991; 5: 780-781.
5. Decker M, Vaughn W, Brodie J, et al. Seroepidemiology of hepatitis B in Tennessee prisoners. J Infect Dis 1984; 150: 450-458.
6. Chiaramonte M, Trivello R, Renzulli G, et al. Hepatitis B virus infection in prisons. J Hyg Camb 1982; 89: 53-58.
7. Vlahov D, Nelson K, Quinn T, Kendig N. Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland. Eur J Epidemiol 1993; 9: 566-569.
8. Fairley CK, Leslie DE, Nicholson S, et al. Epidemiology and hepatitis C virus in Victoria. Med J Aust 1990; 153: 271-273.
9. Corrections Health Service. Strategic Plan 1993-1998. Sydney: NSW Health Department, 1994.
10. Douglas RM, Gaughwin MD, Ali RL, et al. Risk of transmission of the human immunodeficiency virus in the prison setting [letter]. Med J Aust 1989; 150: 722.
11. Crofts N, Stewart T, Hearne P, et al. Spread of blood borne viruses among Australian prison entrants. BMJ 1995; 310: 285-288.
12. Epi Info [computer program], version 6.0. Atlanta, Ga: Centers for Disease Control, 1994.
13. SPSS-6: Statistical package for the social sciences [computer program], version 6. Chicago, III: SPSS Inc. 1994.
14. Crofts N, Hopper J, Bowden S, et al. Hepatitis C virus infection among a cohort of Victorian injecting drug users. Med J Aust 1993; 159: 237-241.
15. Bayas J, Bruguera M, Martin V, et al. Hepatitis B vaccination in prisons: the Catalonian experience. Vaccine 1993; 11: 1441-1444.
16. Kaldor J, Archer, G, Buring M, et al. Risk factors for hepatitis C virus infection in blood donors: a case-control study. Med J Aust 1992; 157: 227-230.
17. Holsen DS. Prevalence of antibodies to hepatitis C virus and association with intravenous drug abuse and tattooing in a national prison in Norway. Eur J Clin Microbiol Infect Dis 1993; 12: 673-676.